These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1388819)

  • 1. Interaction of carboplatin with carrier human erythrocytes.
    Tonetti M; Gasparini A; Giovine M; Bini D; Mazzucotelli A; De Paz F; Benatti U; De Flora A
    Biotechnol Appl Biochem; 1992 Jun; 15(3):267-77. PubMed ID: 1388819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro studies of amikacin-loaded human carrier erythrocytes.
    Gutiérrez Millán C; Bax BE; Castañeda AZ; Marinero ML; Lanao JM
    Transl Res; 2008 Aug; 152(2):59-66. PubMed ID: 18674740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Encapsulation of adriamycin in human erythrocytes.
    De Flora A; Benatti U; Guida L; Zocchi E
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):7029-33. PubMed ID: 3462740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines.
    Robson H; Meyer S; Shalet SM; Anderson E; Roberts S; Eden OB
    Med Pediatr Oncol; 2002 Dec; 39(6):573-80. PubMed ID: 12376980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antitumor effect of liposome-entrapped carboplatin after intraperitoneal administration in rats].
    Yasui T; Mizuno I; Ichino T; Akamo Y; Yamamoto T; Itabashi Y; Saito T; Kurahashi S; Tanimoto N; Yura J
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1753-5. PubMed ID: 1530349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entrapment of protein protease inhibitors in red blood cells.
    Falcioni G; Gabbianelli R; Santroni AM; Concetti A; Zolla L; Brunori M
    Biotechnol Appl Biochem; 1992 Dec; 16(3):269-74. PubMed ID: 1282323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemically altered human erythrocytes as a carrier for targeted delivery of primaquine: an in vitro study.
    Alanazi FK; Harisa Gel-D; Maqboul A; Abdel-Hamid M; Neau SH; Alsarra IA
    Arch Pharm Res; 2011 Apr; 34(4):563-71. PubMed ID: 21544721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose individualization of carboplatin after a 120-hour infusion schedule: higher dose intensity but fewer toxicities.
    Mercier C; Ciccolini J; Pourroy B; Fanciullino R; Duffaud F; Digue L; Tranchand B; Monjanel-Mouterde S; Guillet P; Nicoara A; Baciuchka M; Bagarry-Liegey D; Lacarelle B; Noble A; Durand A; Favre R
    Ther Drug Monit; 2006 Apr; 28(2):212-8. PubMed ID: 16628133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug, enzyme and peptide delivery using erythrocytes as carriers.
    Millán CG; Marinero ML; Castañeda AZ; Lanao JM
    J Control Release; 2004 Feb; 95(1):27-49. PubMed ID: 15013230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effects of liposome-entrapped carboplatin (Lipo-CBDCA) after intraperitoneal administration in rats bearing carcinomatous peritonitis].
    Mizuno I; Yasui T; Takeyama H; Ishikawa M; Terada J; Mohri N; Ueda T; Sumita N; Kobayashi K; Akamo Y
    Gan To Kagaku Ryoho; 1995 Sep; 22(11):1598-601. PubMed ID: 7574769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and in vitro characterization of carrier erythrocytes for vaccine delivery.
    Hamidi M; Zarei N; Zarrin AH; Mohammadi-Samani S
    Int J Pharm; 2007 Jun; 338(1-2):70-8. PubMed ID: 17317049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group.
    Mandal R; Kalke R; Li XF
    Chem Res Toxicol; 2004 Oct; 17(10):1391-7. PubMed ID: 15487901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with the performance of carrier erythrocytes obtained by hypotonic dialysis.
    Gutiérrez Millán C; Zarzuelo Castañeda A; Sayalero Marinero ML; Lanao JM
    Blood Cells Mol Dis; 2004; 33(2):132-40. PubMed ID: 15315791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of glucose oxidase-loaded human erythrocytes: a model of oxidative cytotoxicity.
    De Flora A; Guida L; Zocchi E; Tonetti M; Benatti U
    Ital J Biochem; 1986; 35(5):361-7. PubMed ID: 3804702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of carbonate in the cytotoxicity of carboplatin.
    Di Pasqua AJ; Goodisman J; Kerwood DJ; Toms BB; Dubowy RL; Dabrowiak JC
    Chem Res Toxicol; 2007 Jun; 20(6):896-904. PubMed ID: 17497898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Encapsulation by hypotonic dialysis in human erythrocytes: a diffusion or endocytosis process.
    DeLoach JR; Droleskey RE; Andrews K
    Biotechnol Appl Biochem; 1991 Feb; 13(1):72-82. PubMed ID: 2054104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythrocytes as carrier for prednisolone: in vitro and in vivo evaluation.
    Shavi GV; Doijad RC; Deshpande PB; Manvi FV; Meka SR; Udupa N; Omprakash R; Dhirendra K
    Pak J Pharm Sci; 2010 Apr; 23(2):194-200. PubMed ID: 20363699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and in vitro characterization of a magnetically responsive ibuprofen-loaded erythrocytes carrier.
    Vyas SP; Jain SK
    J Microencapsul; 1994; 11(1):19-29. PubMed ID: 8138871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes.
    Gutiérrez Millán C; Zarzuelo Castañeda A; González López F; Sayalero Marinero ML; Lanao JM
    J Antimicrob Chemother; 2008 Feb; 61(2):375-81. PubMed ID: 18096557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red blood cells as carriers for delivering of proteins.
    Zolla L; Lupidi G; Marcheggiani M; Falcioni G; Brunori M
    Ann Ist Super Sanita; 1991; 27(1):97-103. PubMed ID: 1958034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.